Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Ischemia » Infarction
Diseases [C] » Pathological Conditions, Signs and Symptoms [C23] » Pathologic Processes » Necrosis » Infarction
Description
Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS. MeSH
Hierarchy View
Subtype Terms (5)
Brain Infarction
11 drugs (7 approved, 4 experimental)
Myocardial Infarction
296 drugs (174 approved, 122 experimental)
Pulmonary Infarction
1 approved drug
Phase 4 Indicated Drugs (3)
Phase 1 Indicated Drugs (1)
Organization Involved with Phase 4 Indications (268)
Beijing Bozhiyin T&S Co., Ltd.
Burnasyan Federal Medical Biophysical Center
Canadian Institutes of Health Research (CIHR)
Catholic University of Sacred Heart, Rome
China Resources Zizhu Pharmaceutical Co., Ltd.
Chinese Academy of Medical Sciences
CHINESE ARMED POLICE FORCE GENRAL HOSPITAL
Chinese Center of Diseases Control and Prevention
Federal University of Rio Grande do Sul
Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital
Finnish Foundation for Cardiovascular Research
Fondo de Investigacion Sanitaria
Fundação de Amparo à Pesquisa do Estado de São Paulo
Fundacja Ośrodek Badań Medycznych
General Hospital of Chinese Armed Police Forces
Guangdong Provincial Hospital of Traditional Chinese Medicine
Guangzhou Recomgen Biotech Co., Ltd.
Hamilton Health Sciences Corporation
Helena Laboratories Point of Care
Huazhong University of Science and Technology
Icahn School of Medicine at Mount Sinai
Imam Abdulrahman Bin Faisal University
Instituto Dante Pazzanese de Cardiologia
Instituto Mexicano del Seguro Social
Isala Clinics, Zwolle, The Netherlands
Istituto Clinico Humanitas - Rozzano (MI), Italy
Istituto Clinico Sant'Ambrogio
Katholieke Universiteit Leuven
King Fahad Armed Forces Hospital
Korean Society of Interventional Cardiology
Krakowskie Centrum Kardiologii Inwazyjnej, Elektroterapii i Angiologii Carint Scanmed Sp. z o.o
Kyoto Prefectural University of Medicine
Life Sciences Research Partners
Misericordia and Dolce Hospital
Mochida Pharmaceutical Company, Ltd.
Myung In Pharmaceutical Company
National Health and Medical Research Council, Australia
National Heart, Lung, and Blood Institute (NHLBI)
National Institute of Neurological Disorders and Stroke (NINDS)
National Natural Science Foundation of China
National University of Singapore
Nicolaus Copernicus University
Norra Alvsborgs Lans Hospital, Trollhattan
Norwegian University of Science and Technology
Osaka Acute Coronary Insufficiency Study Group
Ospedale della Misericordia - Grosseto
Ospedale Misericordia e Dolce, Prato
People's Liberation Army of China
Platelet and Thrombosis Research L.L.C
Shanghai Xuhui District Central Hospital
Silesian University of Medicine
St. Antonius Hospital, Nieuwegein
Stockholm South General Hospital
Taichung Veterans General Hospital
Teaching Hospital Královské Vinohrady (FNKV)
Technical University of Munich
The Royal Wolverhampton NHS Trust
Universidad Complutense de Madrid
University Hospital of North Norway
University of British Columbia
University of Campania Luigi Vanvitelli
University of Eastern Piedmont
University of Modena and Reggio Emilia
University of Roma La Sapienza
University of Southern Denmark
University of Texas at Houston
Virginia Commonwealth University
Organization Involved with Phase 3 Indications (208)
ARTTIC International Management Services
Badalona Hospital Germans Trias i Pujol
Baqiyatallah Medical Sciences University
Basildon and Thurrock University Hospitals NHS Foundation Trust
Bharat Biotech International Limited
Boston Health and Hospitals Department
Brazilian Clinical Research Institute
Canadian Heart Research Centre
CardioVascular Research Foundation, Korea
Cardiovascular Research Foundation, New York
Centers for Disease Control and Prevention (CDC)
Central Army Hospital RSPAD Gatot Soebroto
Chinese People's Armed Police Forces
Clinical Hospital #15 Clinical Hospital #15 named after O.M.Filatov, Moscow, Russia
Foundation to Promote Research into Functional Vitamin B12 Deficiency, Bergen, Norway
Greater Baltimore Medical Center
Health Care Centers of Illinois
Heart and Stroke Foundation of Canada
Hellenic Cardiovascular Research Society
Hospital Alessandro Manzoni Lecco
Hospital e Maternidade Celso Pierro
Hospital General Universitario Gregorio Marañon
Hospital Universitario Virgen Macarena
Indonesia's Neurologists Organization (Perdossi)
Institute of Cardiology, Tomsk, Russia
Institut National de la Santé Et de la Recherche Médicale, France
Instituto de Ciencias del Corazon
Investigación Independiente S.A.
Iuliu Hatieganu University of Medicine and Pharmacy
Japan Cardiovascular Research Foundation
Kennedy-Leigh charitable trust
Maryland Medical Research Institute
Mt. Sinai Medical Center, Miami
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)
National Cerebral and Cardiovascular Center
National Institutes of Health (NIH)
Norwegian Heart and Lung Patient Organisation
Pacific Health Research Institute
Palo Alto Medical Research Foundation
Prairie Vascular Research Inc.
Prairie Vascular Research Network, Regina, Saskatchewan
Romania:The National Authority for Scientific Research
Rusculleda Foundation Instituto DAMIC
Russian Academy of Medical Sciences
Salt Lake Clinic Research Foundation
San Carlos University Hospital, Madrid
Shenzhen Salubris Pharmaceuticals Co., Ltd.
South Australian Health and Medical Research Institute
Stiftung Institut fuer Herzinfarktforschung
St. Joseph Hospital Health Center
Suzhou Landing Pharmaceuticals
Swedish Foundation for Strategic Research
The Society of Cardiac Health Protection
The University of Texas, Dallas
Thrombolysis in Myocardial Infarction Study Group
Tokyo Women's Medical University
Universidad Autonoma de Barcelona
Universidad Autonoma de Madrid
University of Alabama, Birmingham
University of California, Davis
University of California, Santa Cruz
University of Las Palmas de Gran Canaria
University of Medicine and Dentistry of New Jersey
University of Nice Sophia Antipolis
University of Southern California
Urmia University of Medical Sciences
Vall d'Hebron Institute of Research, Galatea Clinic
Washington University in St. Louis
ZonMw: The Netherlands Organisation for Health Research and Development
Organization Involved with Phase 2 Indications (146)
Albany College of Pharmacy and Health Sciences
Apeloa Pharmaceutical Co. Ltd.
Applied Health Research Centre
Azienda Ospedaliera Ospedale Civile di Legnano
Azienda Ospedaliera San Gerardo di Monza
Azienda Ospedaliera Sant'Anna e San Sebastiano
Bhagwan Mahaveer Jain Hospital
California Institute for Regenerative Medicine
Cellonis Biotechnology Co. Ltd.
Centro Cardiologico Monzino IRCCS
Dr. Sami Ulus Children's Hospital
Federal University of Santa Catarina
Fibrex Medical Research & Development GmbH
First People's Hospital of Foshan
Fondazione Poliambulanza Istituto Ospedaliero
Foundation for Biomedical Research and Innovation
Foundation IRCCS San Matteo Hospital
Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Gottfried Wilhelm Leibniz Universität Hannover
Inner Mongolia International Mongolian Hospital
Nanyang Technological University
National Institute for Health Research, United Kingdom
National Institute on Aging (NIA)
National University of Ireland
National University of Malaysia
Ospedale Bassini Cinisello Balsamo
Papworth Hospital NHS Foundation Trust
Rawalpindi Institute of Cardiology
RegeneRx Biopharmaceuticals, Inc.
Sclnow Biotechnology Co., Ltd.
Second People's Hospital of Nanhai District of Foshan
Shantou University Medical College
Shifa Tameer-e-Millat University
South China Research Center for Stem Cell and Regenerative Medicine
Organization Involved with Phase 1 Indications (20)
Organization Involved with Other Experimental Indications (67)
Canadian Anesthesiologists' Society
Centre Hospitalier Sainte-Anne
Chalmers University of Technology
Changchun University of Chinese Medicine
Dongfang Hospital Beijing University of Chinese Medicine
European Research Advisory Board
First People's Hospital of Shenyang
General Hospital of Shenyang Military Region
Jiangmen Wuyi Hospital of Traditional Chinese Medicine
National Research Foundation of Korea
Puyang Oil Field General Hospital
Shandong University of Traditional Chinese Medicine
The Council on Health and Rehabilitation, Norway
The First People's Hospital of Shangqiu
The First People's Hospital of Xinmi
The First People's Hospital of Zhumadian
The International Federation of Red Cross and Red Crescent Societies
The Norwegian Council on Cardiovascular Disease
The Peoples' Hospital of Jiaozuo City
The second people's Hospital of Jiyuan
The Second People's Hospital of Pingdingshan
The Young Investigator Group of Cardiovascular Research
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
